Binding of [3H] (2S,1′S,2′S)-2-(9-xanthylmethyl)-2-(2′-carboxycycloprophyl) glycine ([3H]LY341495) to cell membranes expressing recombinant human group III metabotropic glutamate receptor subtypes

被引:48
作者
Wright, RA [1 ]
Arnold, MB [1 ]
Wheeler, WJ [1 ]
Ornstein, PL [1 ]
Schoepp, DD [1 ]
机构
[1] Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN 46285 USA
关键词
LY341495; metabotropic glutamate receptors; group III mGlu receptors; radioligand; receptor binding;
D O I
10.1007/s002100000305
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
LY341495 is a highly potent and selective antagonist for group II mGlu receptors (mGlu2 and mGglu3). High affinity binding of [H-3]LY341495 to recombinant human group II mGlu receptors (mGlu2 and mGlu3), and in rat brain homogenates (K-d similar to 1 nM), has been previously described. Although LY341495 is a very selective nM-potent antagonist for group II mGlu receptors, it is also a relatively potent antagonist for group III mGlu receptors at high nanomolar to low micromolar concentrations. In this study we examined and characterized the binding of [H-3]LY341495 to membranes of cells expressing recombinant human group III mGlu receptors. Using up to 100 nM of [H-3]LY341495, the level of specific binding in human mGlu4a receptor-expressing cell membranes was not appreciable and binding to this site was not examined further. In contrast, we demonstrated sufficient specific binding of [H-3]LY341495 to human mGlu6, mGlu7a and mGlu8a receptor-expressing cell membranes to allow for further characterizations. [H-3]LY341495 binding was saturable and rapidly reversible. [H-3]LY341495 bound to a single site in each cell line, with K-d and B-max values of 31.6+/-6.8 nM and 3.3+/-0.7 pmol/mg protein (mGlu6), 72.7+/-22.0 nM and 3.7+/-0.4 pmol/mg protein (mGlu8a), and 14.0+/-1.1 nM and 3.0+/-0.2 pmol/mg protein (mGlu8a), [H-3]LY341495 binding to mGlu6, 7a and 7a was displaceable by compounds which interact functionally with group III mGlu receptors. For example, L-AP4 displaced [H-3]LY341495 with Ki values of 6.8+/-3.1 muM (mGlu6), 211+/-43 muM (mGlu7a) and 1.6+/-0.3 muM (mGlu8a). With L-glutamate, we obtained K-i values of 12.3+/-3.5, 869+/-154 and 4.5+/-0.83 muM, for mGlu6, mGlu7a and mGlu8a, respectively. K-i values for unlabelled LY341495 were 0.058+/-0.008, 0.22+/-0.05 and 0.029+/-0.008 muM, respectively. These studies demonstrated that [H-3]LY341495 is a useful radioligand for studying the pharmacology and expression of recombinant mGlu6, 7a and 8a receptors in cell lines.
引用
收藏
页码:546 / 554
页数:9
相关论文
共 39 条
[21]   [3H]LY341495, a highly potent, selective and novel radioligand for labeling group II metabotropic glutamate receptors [J].
Ornstein, PL ;
Arnold, MB ;
Bleisch, TJ ;
Wright, RA ;
Wheeler, WJ ;
Schoepp, DD .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (14) :1919-1922
[22]   Organization of glutamate receptors at the synapse [J].
Ottersen, OP ;
Landsend, AS .
EUROPEAN JOURNAL OF NEUROSCIENCE, 1997, 9 (11) :2219-2224
[23]  
PIN JP, 1995, NEUROPHARMACOLOGY, V34, P1, DOI 10.1016/0028-3908(94)00129-G
[24]   1S,3R-ACPD-SENSITIVE (METABOTROPIC) [H-3] GLUTAMATE RECEPTOR-BINDING IN MEMBRANES [J].
SCHOEPP, DD ;
TRUE, RA .
NEUROSCIENCE LETTERS, 1992, 145 (01) :100-104
[25]   METABOTROPIC GLUTAMATE RECEPTORS IN BRAIN-FUNCTION AND PATHOLOGY [J].
SCHOEPP, DD ;
CONN, PJ .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1993, 14 (01) :13-20
[26]   LY354740 is a potent and highly selective group II metabotropic glutamate receptor agonist in cells expressing human glutamate receptors [J].
Schoepp, DD ;
Johnson, BG ;
Wright, RA ;
Salhoff, CR ;
Mayne, NG ;
Wu, S ;
Cockerham, SL ;
Burnett, JP ;
Belegaje, R ;
Bleakman, D ;
Monn, JA .
NEUROPHARMACOLOGY, 1997, 36 (01) :1-11
[27]   The novel metabotropic glutamate receptor agonist 2R,4R-APDC potentiates stimulation of phosphoinositide hydrolysis in the rat hippocampus by 3,5-dihydroxyphenylglycine: Evidence for a synergistic interaction between group 1 and group 2 receptors [J].
Schoepp, DD ;
Salhoff, CR ;
Wright, RA ;
Johnson, BG ;
Burnett, JP ;
Mayne, NG ;
Belagaje, R ;
Wu, S ;
Monn, JA .
NEUROPHARMACOLOGY, 1996, 35 (12) :1661-1672
[28]   Pharmacological agents acting at subtypes of metabotropic glutamate receptors [J].
Schoepp, DD ;
Jane, DE ;
Monn, JA .
NEUROPHARMACOLOGY, 1999, 38 (10) :1431-1476
[29]  
SCHOEPP DD, 1994, J NEUROCHEM, V63, P769
[30]   Structure-activity relationships of new agonists and antagonists of different metabotropic glutamate receptor subtypes [J].
Sekiyama, N ;
Hayashi, Y ;
Nakanishi, S ;
Jane, DE ;
Tse, HW ;
Birse, EF ;
Watkins, JC .
BRITISH JOURNAL OF PHARMACOLOGY, 1996, 117 (07) :1493-1503